Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fluorescence Analyzers Evaluated for Diagnoses of UTIs

By LabMedica International staff writers
Posted on 10 Sep 2018
Urinary tract infections (UTIs) are among the most frequent infections in both hospitalized and outpatients. More...
As a result, urine specimens constitute a significant proportion of routine microbiology laboratory workload.

Traditional culture remains the “gold standard” for the diagnostic evaluation of patients suspected of having a UTI as it allows the identification of the etiological agents, to estimate the concentration of isolated microorganisms and to offer susceptibility testing for targeting the optimal antibiotic therapy.

Medical microbiologists at the Pordenone Hub Hospital (Pordenone, Italy) evaluated 2,719 midstream urine samples from 1,198 (44.1%) male and 1,521 (55.9%) female, aged from 0 and 97 years (median age = 66 years), submitted to the microbiology laboratory with a specific request for urine culture. Inpatients were 23.9% and outpatients 76.1%. The study was conducted from April 6 to June 12, 2017.

All specimens that passed an exclusion criterion were analyzed with the Sysmex UF-5000 (Sysmex Corporation, Kobe, Japan). The analyzer can discriminate and count 17 diagnostic parameters of cells and formed elements in urine and offers an integrated body fluid mode (BF), available on the instrument with a switch, which can classify and count seven diagnostic parameters. The system employs fluorescence flow cytometry technology, using a new blue semi-conductor laser at 488 nm wavelength, Gram staining of centrifuged specimens was conducted in case of discrepancies between the results of the UF-5000 Bact Info flag and the culture method.

The scientists reported that of the 2,719 samples, 1,922 (70.7%) were negative in urine culture (sterile or ≤ 104 CFU/mL) and 797 (29.3%) showed significant growth. In 574 of the positive samples a single microorganism was identified, in 71 samples two microorganisms were isolated, and 152 samples showed mixed flora. The microorganisms isolated reflected the usual rate of uropathogens in their laboratory, so that the most frequent bacteria reported were Gram negatives accounting for 76.9% of all species isolated, and the majority were Enterobacteriaceae. The UF-5000 showed a very good performance in the screening process. Carryover and cross-contamination was negligible and 797 samples were culture positive at a cut-off of ≥105CFU/mL.

The authors concluded that the new Sysmex UF-5000 showed high diagnostic accuracy in UTI-screening with a very low rate of false negatives. The instrument is capable of predicting Gram negatives with a good standard error and a high agreement with the culture, even if this performance needs further evaluation. The study was published in the September 2018 issue of the journal Clinica Chimica Acta.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.